Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/8/23 07:00 | 6/7/23 | TOVX | Health | Drug | Pharmaceutical Preparations | Shallcross Steven A | MD | DO | CEO,CFO | P | 10 | 0.6931 | 0 | 14 | 6 | 250 | D | ||||||||||||||
6/7/23 07:00 | 6/6/23 | TOVX | Health | Drug | Pharmaceutical Preparations | Shallcross Steven A | MD | DO | CEO,CFO | P | 16 | 0.6328 | 0 | 26 | 12 | 236 | D | ||||||||||||||
2/13/23 06:06 | 2/10/23 | TOVX | Health | Drug | Pharmaceutical Preparations | Shallcross Steven A | MD | DO | CEO,CFO | P | 26 | 1.04 | 0 | 25 | 14 | 210 | D | ||||||||||||||
2/3/23 06:02 | 2/2/23 | TOVX | Health | Drug | Pharmaceutical Preparations | Shallcross Steven A | MD | DO | CEO,CFO | P | 24 | 0.9405 | 0 | 25 | 16 | 185 | D | ||||||||||||||
1/26/23 06:03 | 1/25/23 | TOVX | Health | Drug | Pharmaceutical Preparations | Shallcross Steven A | MD | DO | CEO,CFO | P | 22 | 0.8730 | 0 | 25 | 19 | 160 | D | ||||||||||||||
1/23/23 06:08 | 1/20/23 | TOVX | Health | Drug | Pharmaceutical Preparations | Shallcross Steven A | MD | DO | CEO,CFO | P | 19 | 0.7482 | 0 | 25 | 23 | 135 | D | ||||||||||||||
1/3/23 06:04 | 12/29/22 | TOVX | Health | Drug | Pharmaceutical Preparations | Shallcross Steven A | MD | DO | CEO,CFO | P | 44 | 0.4370 | 0 | 100 | 999% | 110 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |